This HTML5 document contains 113 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51803777
rdf:type
wikibase:Item
schema:description
artigo científico מאמר מדעי wissenschaftlicher Artikel научни чланак article scientific мақолаи илмӣ 2009年学术文章 scientific article published on 23 February 2009 სამეცნიერო სტატია artigo científico wetenschappelijk artikel scienca artikolo 2009年学术文章 2009年學術文章 articolo scientifico videnskabelig artikel 2009年の論文 научная статья επιστημονικό άρθρο artikull shkencor artykuł naukowy наукова стаття, опублікована в лютому 2009 2009年学术文章 научни чланак article scientifique bài báo khoa học 2009年学术文章 teaduslik artikkel artikel ilmiah artículu científicu 2009年學術文章 vedecký článok 2009 nî lūn-bûn vědecký článek artículo científico publicado en 2009 scientific article published on 23 February 2009 artigo científico tudományos cikk 2009年學術文章 articol științific bilimsel makale naučni članak tieteellinen artikkeli 2009년 논문 ২৩ ফেব্রুয়ারি ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel artikulong pang-agham مقالة علمية نشرت في 23 فبراير 2009 vetenskaplig artikel บทความทางวิทยาศาสตร์ article científic 2009年學術文章 2009年学术文章 2009年學術文章 2009年学术文章 научна статия vitenskapelig artikkel scientific article published on 23 February 2009
p:P577
wds:Q51803777-4809A319-830D-421C-BC57-CE6B5B8A10DA
wdt:P577
2009-02-23T00:00:00Z
p:P407
wds:Q51803777-26E34F0C-3464-4D78-83A1-F1FE3748AA16
wdt:P407
wd:Q1860
p:P2093
wds:Q51803777-4EB51CA8-8D48-454C-9D4C-A403D001186D wds:Q51803777-9135233E-29BA-424B-9F76-A20A33640136 wds:Q51803777-D3A5221C-DF2A-4731-8183-2051E89A32C4 wds:Q51803777-EA2C9AD8-B8A6-4495-B471-BB83EC2C5556 wds:Q51803777-EC5652A8-3E68-40EC-8DEA-EDCC4636EB3D wds:Q51803777-06797DC1-C8D4-48FE-9404-CAA97DEF1CF7 wds:Q51803777-1E904318-1249-4758-88F6-235395FA2018 wds:Q51803777-45D61613-75C5-46F0-B774-04D05449535E
wdt:P2093
Allan Lipton Guozhi Gao Susie Jun Julie R Gralow Jean-Jacques Body Ling Wu Winnie Sohn Yasmin Rahim
rdfs:label
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
skos:prefLabel
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
schema:name
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
p:P50
wds:Q51803777-EBCE331B-CC36-4CA7-A173-E25A9C8E7776 wds:Q51803777-6B451BC4-E3CF-405F-BCB2-2F216DDB2125
wdt:P50
wd:Q73569107 wd:Q93104907
p:P1476
wds:Q51803777-15EB7BF3-848F-4CE7-8C06-2D5417777499
wdt:P1476
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
p:P304
wds:Q51803777-3956524A-F8F4-4606-824B-CA931A9D0CB5
wdt:P304
1564-1571
p:P31
wds:Q51803777-75730523-3AB5-47BA-9855-485874BD555B
wdt:P31
wd:Q13442814
p:P921
wds:Q51803777-675882BC-B160-4A4B-BAB6-2A7D48B50981 wds:Q51803777-72F6A6D9-3BED-49C3-86AA-37FB66C69210 wds:Q51803777-3528517C-AF35-4352-BB9B-299771555CDE
wdt:P921
wd:Q42824440 wd:Q128581 wd:Q181257
p:P698
wds:Q51803777-C45338FB-A88B-495C-9CCA-ECC6858782B0
wdtn:P698
n11:19237632
wdt:P698
19237632
p:P1433
wds:Q51803777-164CBBE8-8DAE-4F28-A552-5331AC50B82E
wdt:P1433
wd:Q400292
p:P433
wds:Q51803777-A1619BE0-2C53-4751-9C92-B40E5037898C
p:P478
wds:Q51803777-C28B1E7A-2F51-4059-96C2-9EE611EA5C27
wdt:P433
10
wdt:P478
27
p:P356
wds:Q51803777-846CDB9F-E12F-4DE1-9177-225EED4140A1
wdtn:P356
n12:JCO.2008.19.2146
wdt:P356
10.1200/JCO.2008.19.2146